ENVB vs. MRNY
ENVB (Enveric Biosciences Inc) is a stock, while MRNY (YieldMax MRNA Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax. Over the past year, ENVB returned -84.96% vs 42.90% for MRNY. At a 0.21 correlation, their price movements are largely independent.
Performance
ENVB vs. MRNY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVB achieves a -38.84% return, which is significantly lower than MRNY's 43.37% return.
ENVB
- 1D
- -1.77%
- 1M
- -44.36%
- YTD
- -38.84%
- 6M
- -61.86%
- 1Y
- -84.96%
- 3Y*
- -85.38%
- 5Y*
- -84.04%
- 10Y*
- -73.81%
MRNY
- 1D
- -0.33%
- 1M
- 1.83%
- YTD
- 43.37%
- 6M
- 59.24%
- 1Y
- 42.90%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ENVB vs. MRNY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ENVB Enveric Biosciences Inc | -38.84% | -94.37% | -72.43% | -28.57% |
MRNY YieldMax MRNA Option Income Strategy ETF | 43.37% | -35.72% | -59.32% | 19.61% |
Correlation
The correlation between ENVB and MRNY is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 2023 | 0.21 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVB vs. MRNY — Risk / Return Rank
ENVB
MRNY
ENVB vs. MRNY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and YieldMax MRNA Option Income Strategy ETF (MRNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ENVB | MRNY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.49 | 0.88 | -1.37 |
Sortino ratioReturn per unit of downside risk | -0.64 | 1.58 | -2.22 |
Omega ratioGain probability vs. loss probability | 0.92 | 1.19 | -0.27 |
Calmar ratioReturn relative to maximum drawdown | -0.94 | 1.42 | -2.36 |
Martin ratioReturn relative to average drawdown | -1.31 | 2.77 | -4.08 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ENVB | MRNY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.49 | 0.88 | -1.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.54 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.46 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.45 | -0.53 | +0.07 |
Drawdowns
ENVB vs. MRNY - Drawdown Comparison
The maximum ENVB drawdown since its inception was -100.00%, which is greater than MRNY's maximum drawdown of -82.15%. Use the drawdown chart below to compare losses from any high point for ENVB and MRNY.
Loading charts...
Drawdown Indicators
| ENVB | MRNY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -82.15% | -17.85% |
Max Drawdown (1Y)Largest decline over 1 year | -89.71% | -31.53% | -58.18% |
Max Drawdown (3Y)Largest decline over 3 years | -99.79% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -99.99% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -69.82% | -30.18% |
Average DrawdownAverage peak-to-trough decline | -86.06% | -52.59% | -33.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 64.53% | 16.14% | +48.39% |
Volatility
ENVB vs. MRNY - Volatility Comparison
Enveric Biosciences Inc (ENVB) has a higher volatility of 24.87% compared to YieldMax MRNA Option Income Strategy ETF (MRNY) at 12.56%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than MRNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVB | MRNY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.87% | 12.56% | +12.31% |
Volatility (6M)Calculated over the trailing 6-month period | 135.51% | 37.22% | +98.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 173.94% | 49.07% | +124.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 155.93% | 50.67% | +105.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 164.57% | 50.67% | +113.90% |
Dividends
ENVB vs. MRNY - Dividend Comparison
ENVB has not paid dividends to shareholders, while MRNY's dividend yield for the trailing twelve months is around 105.80%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% |
MRNY YieldMax MRNA Option Income Strategy ETF | 105.80% | 145.98% | 178.49% | 1.75% |
Frequently Asked Questions
ENVB and MRNY have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (24.87%) compared to MRNY (12.56%). In terms of maximum drawdown, ENVB dropped -100.00% vs MRNY's -82.15%.
MRNY currently has the higher Sharpe Ratio (0.88 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVB and MRNY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer